scispace - formally typeset
X

Xin Teng

Researcher at Brigham and Women's Hospital

Publications -  7
Citations -  2106

Xin Teng is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Necroptosis & Programmed cell death. The author has an hindex of 6, co-authored 7 publications receiving 1810 citations.

Papers
More filters
Journal ArticleDOI

Identification of RIP1 kinase as a specific cellular target of necrostatins.

TL;DR: Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their respective ligands under conditions where apoptotic execution is prevented and necrostatins are established as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.
Journal ArticleDOI

Structure-activity relationship study of novel necroptosis inhibitors.

TL;DR: 5-(1H-Indol-3-ylmethyl)-2-thiohydantoins and 5-(1h-indol- 3-yl methyl)Hydantoins were found to be potent necroptosis inhibitors (called necrostatins) and several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity.
Journal ArticleDOI

Akt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.

TL;DR: It is shown that Akt kinase activity is critical for necroptosis in L929 cells and plays a key role in TNFα production and the role of AkT kinase in both cell death and inflammatory regulation.
Journal ArticleDOI

Structure–activity relationship study of [1,2,3]thiadiazole necroptosis inhibitors

TL;DR: A structure-activity relationship study revealed that small cyclic alkyl groups and 2,6-dihalobenzylamides at the 4- and 5-positions of the [1,2,3]thiadiazole, respectively, were optimal for necroptosis inhibitory activity.
Journal ArticleDOI

Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors.

TL;DR: A structure-activity relationship (SAR) study of the [1,2,3]thiadiazole benzylamide series revealed that increased mouse liver microsome stability and increased necroptosis inhibitory activity could be accomplished by replacement of the 4-cyclopropyl-[1, 2,3], 5-cyano-1-methylpyrrole derivatives.